Suitable for :

• Biotech startups — companies developing organoid-based disease models, drug screening platforms, or personalized medicine using organoids.
• Organoid imaging & analytics — firms offering optical imaging (OI), high-content microscopy, image analysis, or AI tools for organoid phenotyping.
• Stem cell and regenerative medicine — teams commercializing organoid-derived therapies or tissue engineering solutions.